Company: FENC
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001104659-25-111260
Chunk: 3

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1F
Chunk 3
---
  147,652​  145,608​Additional paid-in capital​  71,249​  66,958​Accumulated deficit​  (224,636)​  (219,681)​Accumulated other comprehensive income​  1,243​  1,243​Total stockholders’ deficit​  (4,492)​  (5,872)​Total liabilities and stockholders’ deficit​$ 49,261​$ 44,946​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.